Corporate Disclosure2026-05-11
Onconic Therapeutics Clinical Trial
온코닉
온코닉테라퓨틱스
476060
Signal Score
50C — Neutral
Score50 / 100
Historical Avg Return (5d)
+0.03%
Data Coverage
100%n=9150
Risk-adjusted indicator based on 9150 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Clinical Trial Phase: 1
- • Target Number of Subjects: 48
3 more figures — unlock with API access
AI Analysis Summary
Developer & Pro plans
Risk Factors
Developer & Pro plans
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Historical pattern data via REST API
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.
AI-processed analysis. Based on: 투자판단관련주요경영사항(임상시험계획변경승인신청) (자큐보구강붕해정(JLP2302)(자스타프라잔시트르산염)의 비위관투여 시 약동학 및 안전성 비교평가를 위한 제1상 임상시험계획승인(변경승인)신청). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.